Drug/Insect/Latex News

A panel of experts at the virtual American Academy of Allergy, Asthma and Immunology Annual Meeting highlighted current evidence on allergic reactions to available COVID-19 vaccines and how to assess patients who have had a reaction.

A study found that “significant desensitization” occurred among peanut-allergic toddlers following peanut sublingual immunotherapy, according to data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

An animated video that was shown to children with a history of food-related anaphylaxis improved their understanding of anaphylaxis and how manage it, data show.

There is “significant variability” in allergen composition, concentration and dose per serving among commercially available early allergen introduction foods, an expert told Healio Primary Care.

Data presented during the American Academy of Allergy, Asthma & Immunology annual meeting indicated that introducing peanuts at an earlier age leads to a decrease in children with peanut allergy later in life.

Anaphylaxis was rarely reported among the first 4 million recipients of the second COVID-19 vaccine authorized for use in the United States, the CDC and FDA reported in MMWR.

As of Dec. 23, there were 21 confirmed cases of anaphylaxis among the first 1,893,360 recipients of the Pfizer/BioNTech COVID-19 vaccine in the United States, the CDC and FDA reported in MMWR.

The American College of Allergy, Asthma and Immunology’s COVID-19 Task Force released guidance on allergic reaction risk from the Pfizer-BioNTech COVID-19 vaccine.

The FDA has approved an intentional genomic alteration process in a line of domestic pigs that is intended to eliminate alpha-gal sugar on the pigs’ cell surfaces.

Approximately one in five children and parents reported being bullied due to the child’s food allergy, survey data showed.